Recro Pharma

Recro Pharma Inc (NASDAQ: REPH) is a clinical-stage pharmaceutical company that engages in the development of products for the treatment of serious acute pain. The company's lead product candidate is called meloxicam, which is an IV intravenous product for relief of serious pain that is...